Growth Metrics

Vycor Medical (VYCO) Cash from Operations Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.78%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 9.30%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 20.35%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 22.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -48.14%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.50%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 50.11%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -14.75%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.83%
10 Vycor Medical - - 375,153.00 59.24%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 59.24%
Dec 31, 2025 47.00%
Sep 30, 2025 1.91%
Jun 30, 2025 54.07%
Mar 31, 2025 30.10%
Dec 31, 2024 -47.62%
Sep 30, 2024 29.42%
Jun 30, 2024 -0.17%
Mar 31, 2024 27.14%
Dec 31, 2023 43.08%
Sep 30, 2023 55.06%
Jun 30, 2023 32.35%
Mar 31, 2023 39.44%
Dec 31, 2022 -107.89%
Sep 30, 2022 -80.90%
Jun 30, 2022 -31.70%
Mar 31, 2022 -63.40%
Dec 31, 2021 6.81%
Sep 30, 2021 -20.09%
Jun 30, 2021 41.28%
Mar 31, 2021 38.19%
Dec 31, 2020 67.72%
Sep 30, 2020 -17.20%
Jun 30, 2020 -87.85%
Mar 31, 2020 47.76%
Dec 31, 2019 26.89%
Sep 30, 2019 108.10%
Jun 30, 2019 59.31%
Mar 31, 2019 55.15%
Dec 31, 2018 31.55%
Sep 30, 2018 51.82%
Jun 30, 2018 25.01%
Mar 31, 2018 33.94%
Sep 30, 2017 32.29%
Jun 30, 2017 78.07%
Mar 31, 2017 40.60%
Dec 31, 2016 -2.13%
Sep 30, 2016 69.96%
Jun 30, 2016 13.99%
Mar 31, 2016 8.80%
Dec 31, 2015 33.32%
Sep 30, 2015 2.01%
Jun 30, 2015 8.67%
Mar 31, 2015 -9.22%
Sep 30, 2014 32.18%
Jun 30, 2014 8.35%
Mar 31, 2014 -27.24%
Dec 31, 2013 33.04%
Sep 30, 2013 32.37%